• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Early postoperative outcomes of modified del Nido cardioplegia in coronary artery bypass surgery in patients with low ejection fraction.低射血分数患者冠状动脉搭桥手术中改良del Nido心脏停搏液的术后早期结果
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Oct 30;32(4):387-393. doi: 10.5606/tgkdc.dergisi.2024.26359. eCollection 2024 Oct.
2
The Effects of Amino Acids Enriched Del Nido Cardioplegia on Myocardial Leucocyte Accumulation and Ventricular Functions in Patients Undergoing Coronary Artery Bypass Grafting Surgery.富含氨基酸的 Del Nido 心脏停搏液对冠状动脉旁路移植术患者心肌白细胞积聚和心室功能的影响。
Heart Surg Forum. 2021 Jan 15;24(1):E038-E047. doi: 10.1532/hsf.3265.
3
Traditional vs. modified Ringer lactate-based del Nido cardioplegia impacts on clinical outcomes in patients undergoing coronary artery bypass grafting: Results from a prospective, randomized, blinded trial.传统与改良乳酸林格氏液基础的德尔尼多心脏停搏液对冠状动脉旁路移植术患者临床结局的影响:一项前瞻性、随机、双盲试验的结果
J Extra Corpor Technol. 2024 Dec;56(4):159-166. doi: 10.1051/ject/2024010. Epub 2024 Sep 20.
4
[MSB-41] Comparison of del Nido Cardioplegia with Blood Cardioplegia in Coronary Artery Bypass Grafting Combined with Mitral Valve Replacement.[MSB - 41] 冠状动脉旁路移植术联合二尖瓣置换术中德尔尼多停搏液与含血停搏液的比较
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Dec 31;32(4 Suppl 2):066-66. doi: 10.5606/tgkdc.dergisi.2024.msb-41. eCollection 2024 Nov.
5
Comparison of Del Nido Cardioplegia and Blood Cardioplegia in Terms of Development of Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting.比较含血停搏液与 Del Nido 停搏液在单纯冠状动脉旁路移植术后心房颤动发生率的差异。
Braz J Cardiovasc Surg. 2021 Apr 1;36(2):158-164. doi: 10.21470/1678-9741-2020-0047.
6
Outcomes of del Nido cardioplegia after surgical aortic valve replacement and coronary artery bypass grafting.在主动脉瓣置换术和冠状动脉旁路移植术后使用德尔尼多停搏液的效果。
Gen Thorac Cardiovasc Surg. 2023 Sep;71(9):491-497. doi: 10.1007/s11748-023-01914-x. Epub 2023 Feb 27.
7
Myocardial protection in cardiac surgery: Del Nido versus blood cardioplegia.心脏手术中的心肌保护:Del Nido 与冷血心脏停搏液。
Ann Card Anaesth. 2020 Oct-Dec;23(4):477-484. doi: 10.4103/aca.ACA_153_19.
8
The application of del Nido cardioplegia for myocardial protection in adult coronary artery bypass grafting: a cohort study.德尔尼多停搏液在成人冠状动脉旁路移植术中心肌保护的应用:一项队列研究。
J Thorac Dis. 2022 Jan;14(1):177-184. doi: 10.21037/jtd-21-1965.
9
Comparison of del Nido Cardioplegia with Blood Cardioplegia in Coronary Artery Bypass Grafting Combined with Mitral Valve Replacement.冠状动脉搭桥术联合二尖瓣置换术中德尔尼多停搏液与血液停搏液的比较
Braz J Cardiovasc Surg. 2018 Sep-Oct;33(5):496-504. doi: 10.21470/1678-9741-2018-0152.
10
Comparative analysis of del Nido cardioplegia versus blood cardioplegia in isolate coronary artery bypass grafting.缺血预处理对体外循环下不停跳冠状动脉旁路移植术患者心肌的影响
J Cardiothorac Surg. 2024 Jul 13;19(1):438. doi: 10.1186/s13019-024-02853-1.

本文引用的文献

1
Outcomes of coronary artery bypass surgery using modified del Nido cardioplegia in patients with poor ventricular function.采用改良 Del Nido 心脏停搏液的冠状动脉旁路移植术治疗心功能不良患者的效果。
J Cardiothorac Surg. 2023 Nov 29;18(1):346. doi: 10.1186/s13019-023-02466-0.
2
Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG.孤立冠状动脉旁路移植术后 5 年预后与术前左心室射血分数的意义。
J Cardiothorac Surg. 2021 Dec 27;16(1):353. doi: 10.1186/s13019-021-01732-3.
3
Transitioning to Del Nido cardioplegia for all-comers: the next switching gear?过渡到所有人都使用 Del Nido 心脏停搏液:下一个切换档位?
BMC Cardiovasc Disord. 2020 May 8;20(1):215. doi: 10.1186/s12872-020-01506-0.
4
Del Nido cardioplegia in coronary surgery: a propensity-matched analysis.冠状动脉手术中的Del Nido心脏停搏液:倾向匹配分析
Interact Cardiovasc Thorac Surg. 2020 May 1;30(5):699-705. doi: 10.1093/icvts/ivaa010.
5
Coronary artery bypass grafting in patients with low ejection fraction: what are the risk factors?射血分数低的患者行冠状动脉搭桥术:危险因素有哪些?
J Cardiovasc Surg (Torino). 2019 Jun;60(3):396-405. doi: 10.23736/S0021-9509.19.10670-2. Epub 2019 Mar 25.
6
The Use of del Nido Cardioplegia for Myocardial Protection in Isolated Coronary Artery Bypass Surgery.-del Nido 心脏停搏液在冠状动脉旁路移植术中的心肌保护作用。
Heart Lung Circ. 2020 Feb;29(2):301-307. doi: 10.1016/j.hlc.2018.12.006. Epub 2019 Jan 18.
7
del Nido cardioplegia in adult cardiac surgery: beyond single-valve surgery.成人心脏手术中的del Nido心脏停搏液:超越单瓣膜手术
Interact Cardiovasc Thorac Surg. 2018 Jul 1;27(1):81-87. doi: 10.1093/icvts/ivy028.
8
Single-dose del Nido Cardioplegia in Minimally Invasive Aortic Valve Surgery.单剂量德尔尼多停搏液在微创主动脉瓣手术中的应用
Semin Thorac Cardiovasc Surg. 2017 Nov 2. doi: 10.1053/j.semtcvs.2017.10.001.
9
Propensity Matched Analysis of del Nido Cardioplegia in Adult Coronary Artery Bypass Grafting: Initial Experience With 100 Consecutive Patients.成人冠状动脉旁路移植术中德尔尼多心脏停搏液的倾向匹配分析:100例连续患者的初步经验
Ann Thorac Surg. 2016 Jun;101(6):2237-41. doi: 10.1016/j.athoracsur.2015.12.058. Epub 2016 Mar 24.
10
del Nido cardioplegia in adult cardiac surgery - scopes and concerns.成人心脏手术中的德尔尼多停搏液——范围与关注点
Perfusion. 2016 Jan;31(1):6-14. doi: 10.1177/0267659115608936. Epub 2015 Oct 7.

低射血分数患者冠状动脉搭桥手术中改良del Nido心脏停搏液的术后早期结果

Early postoperative outcomes of modified del Nido cardioplegia in coronary artery bypass surgery in patients with low ejection fraction.

作者信息

Erol Mehmet Emir, Beyazpınar Deniz Sarp, Civelek İsa, Özyalçın Sertan, Mungan Ufuk

机构信息

Department of Cardiovascular Surgery, Ankara Etlik City Hospital, Ankara, Türkiye.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Oct 30;32(4):387-393. doi: 10.5606/tgkdc.dergisi.2024.26359. eCollection 2024 Oct.

DOI:10.5606/tgkdc.dergisi.2024.26359
PMID:39651058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11620522/
Abstract

BACKGROUND

This study aimed to investigate the intraoperative and early postoperative effects of modified del Nido cardioplegia (DNC) compared to classic blood cardioplegia (BC) in patients with impaired left ventricular ejection fraction (EF) who underwent isolated coronary artery bypass grafting (CABG).

METHODS

A total of 123 patients (108 males, 15 females; mean age: 62.2±8.5 years; range, 42 to 78 years) with an EF of 35% or lower who underwent on-pump CABG were included in the retrospective study between December 2022 and December 2023. The patients were divided into two groups according to the type of cardioplegia used: Group 1 (n=74) was designated as the BC group, and Group 2 (n=49) was designated as the DNC group. The groups were compared in terms of aortic cross-clamp duration, cardiopulmonary bypass (CPB) duration, need for defibrillation during weaning from CPB, positive inotrope requirement, intra-aortic balloon pump requirement, postoperative troponin-I levels, postoperative atrial fibrillation occurence, postoperative prolonged ventilation, development of postoperative neurologic complications, need for reintervention due to postoperative bleeding, postoperative transfusion requirement, and EF values at one month after the operation.

RESULTS

There was no significant difference between the two groups in the terms of aortic cross-clamp and CPB duration (p=0.955 p=0.816). Additionally, there was no significant difference in the need for intra-aortic balloon pump usage between the two groups (p=0.105). Dopamine and dobutamine usage were significantly lower in Group 2 (p=0.04 and p=0.05, respectively). The intraoperative requirement for defibrillation was significantly lower in Group 2 (p=0.01). In addition, troponin levels at 12 h postoperatively were significantly lower in Group 2 (p=0.03). The incidence of postoperative atrial fibrillation was significantly lower in Group 2 (p=0.02). Moreover, there was no significant difference in EF values at one month after the operation (p=0.08).

CONCLUSION

In patients who underwent CABG with reduced EF, modified DNC provided myocardial protection comparable to classic BC. Additionally, the need for intraoperative defibrillation and postoperative inotropic agents, as well as the incidence of postoperative atrial fibrillation, were lower in patients operated with DNC.

摘要

背景

本研究旨在调查在接受单纯冠状动脉旁路移植术(CABG)且左心室射血分数(EF)受损的患者中,改良的del Nido心脏停搏液(DNC)与传统血液心脏停搏液(BC)相比的术中及术后早期效果。

方法

本回顾性研究纳入了2022年12月至2023年12月期间123例接受体外循环CABG且EF为35%或更低的患者(108例男性,15例女性;平均年龄:62.2±8.5岁;范围42至78岁)。根据所用心脏停搏液的类型将患者分为两组:第1组(n = 74)为BC组,第2组(n = 49)为DNC组。比较两组在主动脉阻断时间、体外循环(CPB)时间、CPB脱机期间除颤需求、正性肌力药物需求、主动脉内球囊反搏需求、术后肌钙蛋白I水平、术后房颤发生率、术后长时间通气、术后神经并发症的发生、术后出血导致的再次干预需求、术后输血需求以及术后1个月时的EF值。

结果

两组在主动脉阻断和CPB时间方面无显著差异(p = 0.955,p = 0.816)。此外,两组在主动脉内球囊反搏使用需求方面无显著差异(p = 0.105)。第2组多巴胺和多巴酚丁胺的使用显著更低(分别为p = 0.04和p = 0.05)。第2组术中除颤需求显著更低(p = 0.01)。此外,第2组术后12小时的肌钙蛋白水平显著更低(p = 0.03)。第2组术后房颤发生率显著更低(p = 0.02)。而且,术后1个月时的EF值无显著差异(p = 0.08)。

结论

在接受CABG且EF降低的患者中,改良的DNC提供了与传统BC相当的心肌保护。此外,接受DNC手术的患者术中除颤和术后正性肌力药物的需求以及术后房颤的发生率更低。